Actively Recruiting
Evaluation of Novel and Commercial Diagnostic Blood Tests for Recurrent Angioedema Including Urticarial and Non-Urticarial Types
Led by Foundation For Rare Disease Research · Updated on 2026-08-24
600
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating new and existing diagnostic blood tests to better identify and understand patients who experience recurrent angioedema attacks, which include both urticarial and non-urticarial types. This study aims to compare the effectiveness of novel diagnostic assays alone and in combination with commercial tests to develop an affordable and accurate laboratory test for diagnosing various forms of angioedema. Participants include 300 patients with recurrent angioedema and 300 healthy volunteers without angioedema history. Blood samples will be collected through venipuncture to perform multiple diagnostic tests in specialized laboratories, including immunoassays, flow cytometry, mass spectrometry for bradykinin and histamine detection, and molecular genetic analyses such as sequencing and digital PCR. During the study, participants will provide informed consent and have blood drawn for testing. Researchers will assess novel versus traditional diagnostic tests over two years, including genetic analysis, biomarker development, immunoassays, and lymphocyte profiling. The study focuses on comprehensive assessment through various laboratory techniques to improve future angioedema diagnosis and care.
CONDITIONS
Brief Title
Angioedema Biomarker Research Study
Research Team
H
Henry Li, MD, PhD
J
Joseph Chiao, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here